Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Objective: Infection with Helicobacter pylori is the strongest known risk factor for adenocarcinomaofthestomach.
2
Patients and methods: Between January 1993 and December 2002, 338 consecutive patients underwent surgery for adenocarcinomaofthestomach.
3
To examine the association of Helicobacter pylori infection with adenocarcinomaofthestomach in Japanese patients, we studied 29 patients and 58 matched controls.
Использование термина gastric adenocarcinoma на английском
1
Purpose: Current methods of assessing disease burden in gastricadenocarcinoma are imperfect.
2
The only potentially curative treatment available for gastricadenocarcinoma is surgical resection.
3
Methods: Patients with gastricadenocarcinoma treated with nCMT followed by gastrectomy were evaluated.
4
The incidence of gastricadenocarcinoma was determined at week 54 by histological analysis.
5
Patients with histologically confirmed gastricadenocarcinoma were eligible for the study.
6
For gastricadenocarcinoma, screening in high-risk populations has significantly reduced mortality.
7
Herein, a 72-year-old man with both gastricadenocarcinoma and HL has been presented.
8
Background: Trastuzumab has recently shown efficacy in the treatment of HER2-positive advanced gastricadenocarcinoma.
9
These findings can be used to develop targeted risk reduction programs for gastricadenocarcinoma.
10
The case of a patient with gastricadenocarcinoma with indication for gastrectomy is reported.
11
This condition has only been described in conjunction with primary or metastatic gastricadenocarcinoma.
12
The role of nesting as a CSC marker in gastricadenocarcinoma is largely unknown.
13
Helicobacter pylori (H. pylori) is associated with gastric ulcer and gastricadenocarcinoma.
14
Introduction: Coexistence of a primary gastric lymphoma and a gastricadenocarcinoma is a rare event.
15
Furthermore, we demonstrated that gastricadenocarcinoma tissues and AGS cells exhibited abnormal expression of miR-372.
16
Results: Thirteen thousand five hundred forty-seven patients with gastricadenocarcinoma were identified with complete staging information.